UPDATE: H.R.5773 – To amend title XVIII of the Social Security Act to require electronic prior authorization for covered part D drugs and to provide for other program integrity measures under parts C and D of the Medicare program.

LATEST ACTION: June 20, 2018 - Received in the Senate and Read twice and referred to the Committee on Finance.

BILL TITLE: To amend title XVIII of the Social Security Act to require electronic prior authorization for covered part D drugs and to provide for other program integrity measures under parts C and D of the Medicare program.

BILL SUMMARY:

Preventing Addiction for Susceptible Seniors Act of 2018 or the PASS Act of 2018

This bill alters several requirements under the Medicare prescription drug benefit. Specifically, the bill: (1) requires prescription drug plan sponsors to establish drug management programs for at-risk beneficiaries; (2) requires electronic prescription programs to enable the secure transmittal of prior authorization requests for covered drugs; and (3) establishes individuals who are identified as at-risk beneficiaries for prescription drug abuse as qualifying participants in medication therapy management programs.

The bill also requires the Centers for Medicare & Medicaid Services (CMS) to establish a secure online portal to allow: (1) data sharing among the CMS, Medicare prescription drug benefit plans, and Medicare Advantage (MA) plans; and (2) referrals by such plans of substantiated fraud, waste, or abuse in order to initiate or assist investigations by contracted entities under the Medicare Integrity Program.

The CMS must also: (1) identify outlier prescribers of opioids under Medicare prescription drug benefit plans and MA plans, based on specialty and geographic area; and (2) annually notify such prescribers of their status and provide them with resources on proper prescribing methods.

[NOTE: The contents of this legislative update are current as of 06:00 AM on June 21, 2018.]

BILL NUMBER: 115th Congress: House Bill 5773 (H.R.5773)

CHAMBER OF ORIGIN: U.S. House of Representatives

CURRENT CHAMBER: U.S. Senate

For DETAILED LEGISLATIVE INFORMATION on H.R.5773, visit: https://www.congress.gov/bill/115th-congress/house-bill/5773

BILL TEXT: https://www.congress.gov/bill/115th-congress/house-bill/5773/text

ACTIONS-TO-DATE (ordered by most recent first):

06/20/2018 -- Senate -- Received in the Senate and Read twice and referred to the Committee on Finance.

06/19/2018 -- House -- The title of the measure was amended. Agreed to without objection.

06/19/2018 -- House -- Motion to reconsider laid on the table Agreed to without objection.

06/19/2018 -- House -- On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5258-5259)

06/19/2018 -- House -- DEBATE - The House proceeded with forty minutes of debate on H.R. 5773.

06/19/2018 -- House -- Considered under suspension of the rules. (consideration: CR H5258-5261)

06/19/2018 -- House -- Mr. Roskam moved to suspend the rules and pass the bill, as amended.

06/19/2018 -- House -- Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-761, Part I.

05/16/2018 -- House -- Ordered to be Reported (Amended) by Voice Vote.

05/16/2018 -- House -- Committee Consideration and Mark-up Session Held.

05/11/2018 -- House -- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

05/11/2018 -- House -- Introduced in House.

SPONSOR(S)*:

-- Rep. Roskam, Peter J. [R-IL-6]

CO-SPONSOR(S)*:

[*Note: Sponsors and co-sponsors are current as of June 20, 2018. For the most up-to-date version of the sponsor and co-sponsor lists, visit: https://www.congress.gov/bill/115th-congress/house-bill/5773/cosponsors ]

-- Rep. Sewell, Terri A. [D-AL-7]

-- Rep. Knight, Stephen [R-CA-25]

-- Rep. Sinema, Kyrsten [D-AZ-9]

-- Rep. Johnson, Sam [R-TX-3]

-- Rep. Schweikert, David [R-AZ-6]

-- Rep. Kelly, Mike [R-PA-3]

-- Rep. Renacci, James B. [R-OH-16]

COMMITTEES: Senate Finance Committee; House Ways and Means Committee; House Energy and Commerce Committee.

SUBJECTS: Administrative law and regulatory procedures, Department of Health and Human Services, Drug therapy, Drug trafficking and controlled substances, Drug, alcohol, tobacco use, Fraud offenses and financial crimes, Government information and archives, Health care costs and insurance, Health information and medical records, Medicare, Prescription drugs, Public contracts and procurement, Right of privacy.